A Chinese woman living with ALS held a farewell ceremony at a funeral home to celebrate love, gratitude and life.

ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is ...

The FDA has cleared the initiation of a pivotal Phase 3 trial testing pridopidine in people with early, rapidly progressive ...

CorestemChemon (KOSDAQ: 166480) is entering a critical late-stage phase in the commercialization of its ALS stem cell therapy, Neuronata-R. The company attributes this momentum to advanced domestic ...

I like the fact that this city seems to love me," Isreal Hagan once said of Syracuse. "I love it, and it loves me right back.

Qalsody is one step closer to being covered by public Canadian healthcare systems when used to treat adults with ALS with ...

A Northwestern Medicine study has shed light on a critical molecular mechanism underlying amyotrophic lateral sclerosis (ALS) ...

Researchers developed a blood test that spots ALS with 90% accuracy. The 46-gene panel could cut diagnostic delays that now ...

The man behind the Moose Jaw health centre that has claimed “a 100 per cent success rate in stopping the progression and in ...

ALS is a debilitating paralytic disease characterized by the death of upper and lower motor neurons. Fortunately, ALS is ...

Faced with a bleak prognosis of ALS, 35-year-old Megan Decker, along with her husband, Joey, "want to make as many memories as possible with our children while mommy is still here." ...

PathMaker Neurosystems Inc. ('PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...